Aspirin for primary CVD prevention
Why flagged
On aspirin for primary prevention at age 60+, reversed by USPSTF 2022 (Grade D).
Routine low-dose aspirin for primary prevention in adults…
Increased major hemorrhage (HR 1.38; 95% CI 1.18-1.62) and higher all-cause mortality (5.9% vs. 5.7%) in elderly patients, with no CVD benefit.
Guidelines updated
USPSTF (2022): Grade D against initiating aspirin for pri…
- Prior guidance2016
Routine low-dose aspirin for primary prevention in adults 50-59 years with >= 10% 10-year ASCVD risk (USPSTF, 2016).
- ASPREE2018
Increased major hemorrhage (HR 1.38; 95% CI 1.18-1.62) and higher all-cause mortality (5.9% vs. 5.7%) in elderly patients, with no CVD benefit.
- Reversal2022
Guidelines updated
- Current recommendation
USPSTF (2022): Grade D against initiating aspirin for primary prevention in adults >= 60 years. Grade C (individualized decision) for adults 40-59 years with >= 10% ASCVD risk.